A phase II study of weekly low-dose paclitaxel plus 24-hour infusion of cisplatin as first-line chemotherapy for metastatic breast cancer (MBC)

被引：0
|
作者：
Shen, Y. [1 ]
Hsu, C. [1 ]
Kuo, S. [1 ]
Lu, Y. [1 ]
Lin, C. [1 ]
Huang, C. [1 ]
Cheng, A. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1100
引用
收藏
页数：1
相关论文
共 50 条
  • [31] First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study
    Elserafi, Mostafa M.
    Zeeneldin, Ahmed A.
    Abdelsalam, Ibrahim M.
    Nassar, Hanan R.
    Moneer, Manar M.
    Buhoush, Wafa H.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (01) : 13 - 20
  • [32] TAXOL(R) (paclitaxel) 1-hour infusion plus doxorubicin as first line treatment for metastatic breast cancer (MBC) patients
    Mickiewicz, E
    DiNoto, M
    Bas, C
    Ventriglia, M
    Jovtis, S
    Lewi, D
    Rondinon, M
    Temperley, G
    Trigo, M
    Bertoncin, A
    Pascual, ME
    Uranga, G
    Cazap, E
    Breier, S
    Grasso, S
    Estevez, R
    Rubio, G
    Alvarez, AM
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 677 - 677
  • [33] A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
    Gelmon, KA
    Tolcher, A
    O'Reilly, S
    Campbell, C
    Bryce, C
    Shenkier, T
    Ragaz, J
    Ayers, D
    Nakashima, L
    Rielly, S
    Dulude, H
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1247 - 1249
  • [34] A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer
    Kollmannsberger, C.
    Quietzsch, D.
    Haag, C.
    Lingenfelsers, T.
    Schroeder, M.
    Hartmann, J. T.
    Baronius, W.
    Hempel, V.
    Clemens, M.
    Kanz, L.
    Bokemeyer, C.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 458 - 462
  • [35] A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer
    C Kollmannsberger
    D Quietzsch
    C Haag
    T Lingenfelser
    M Schroeder
    J T Hartmann
    W Baronius
    V Hempel
    M Clemens
    L Kanz
    C Bokemeyer
    British Journal of Cancer, 2000, 83 : 458 - 462
  • [36] A phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer (MBC): Interim safety results
    Brufsky, A. M.
    Hoelzer, K. L.
    Keaton, M. R.
    Beck, J. T.
    Krill-Jackson, E.
    Wang, Y.
    Hu, S.
    Vaughn, L. G.
    Shonukan, O. O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Low-dose oral fluorouracil with eniluracil as first-line chemotherapy against advanced breast cancer: A phase II study
    Smith, IE
    Johnston, SRD
    O'Brien, MER
    Hickish, TF
    de Boer, RH
    Norton, A
    Cirkel, DT
    Barton, CM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2378 - 2384
  • [38] Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: Results of a phase II study
    Klaassen, U
    Wilke, H
    Muller, C
    Borquez, D
    Harstrick, A
    Seeber, S
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 58 - 60
  • [39] Weekly low dose paclitaxel and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer
    Kim, SW
    Suh, C
    Lee, SD
    Kim, WS
    Kim, DS
    Kim, WD
    Lee, JS
    LUNG CANCER, 2003, 41 (02) : 221 - 226
  • [40] Low dose sequential docetaxel-capecitabine chemotherapy as first-line treatment of metastatic breast cancer (mbc)
    Hafeez, M.
    Shaharyar, A.
    Masood, A. I.
    Zikria, M.
    Usman, A.
    Shabbir, K.
    Nadeem, Z.
    Tahir, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345